Shenzhen Noposion Crop Science Past Earnings Performance
Past criteria checks 5/6
Shenzhen Noposion Crop Science has been growing earnings at an average annual rate of 13.7%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 2.6% per year. Shenzhen Noposion Crop Science's return on equity is 9.8%, and it has net margins of 8.9%.
Key information
13.7%
Earnings growth rate
11.3%
EPS growth rate
| Chemicals Industry Growth | 12.1% |
| Revenue growth rate | 2.6% |
| Return on equity | 9.8% |
| Net Margin | 8.9% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Shenzhen Noposion Crop Science makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 4,955 | 443 | 1,003 | 147 |
| 30 Jun 24 | 4,973 | 450 | 1,033 | 133 |
| 31 Mar 24 | 4,601 | 472 | 921 | 128 |
| 31 Dec 23 | 4,120 | 236 | 775 | 119 |
| 30 Sep 23 | 4,119 | 307 | 732 | 131 |
| 30 Jun 23 | 4,187 | 345 | 708 | 128 |
| 31 Mar 23 | 4,337 | 381 | 714 | 125 |
| 01 Jan 23 | 4,265 | 328 | 694 | 126 |
| 30 Sep 22 | 4,404 | 276 | 726 | 113 |
| 30 Jun 22 | 4,522 | 323 | 727 | 110 |
| 31 Mar 22 | 4,556 | 323 | 732 | 110 |
| 01 Jan 22 | 4,501 | 305 | 742 | 107 |
| 30 Sep 21 | 4,112 | 212 | 717 | 99 |
| 30 Jun 21 | 4,203 | 197 | 731 | 102 |
| 31 Mar 21 | 4,167 | 184 | 725 | 101 |
| 31 Dec 20 | 4,131 | 167 | 715 | 99 |
| 30 Sep 20 | 4,164 | 259 | 699 | 86 |
| 30 Jun 20 | 4,138 | 240 | 710 | 91 |
| 31 Mar 20 | 4,141 | 229 | 742 | 87 |
| 31 Dec 19 | 4,058 | 236 | 744 | 93 |
| 30 Sep 19 | 4,098 | 296 | 734 | 97 |
| 30 Jun 19 | 4,108 | 313 | 729 | 99 |
| 31 Mar 19 | 4,070 | 306 | 737 | 95 |
| 31 Dec 18 | 4,005 | 329 | 742 | 99 |
| 30 Sep 18 | 3,758 | 354 | 718 | 99 |
| 30 Jun 18 | 3,511 | 359 | 641 | 143 |
| 31 Mar 18 | 2,997 | 355 | 619 | 121 |
| 31 Dec 17 | 2,822 | 309 | 654 | 90 |
| 30 Sep 17 | 2,497 | 214 | 635 | 72 |
| 30 Jun 17 | 2,214 | -28 | 869 | 0 |
| 31 Mar 17 | 2,166 | -239 | 1,108 | 0 |
| 31 Dec 16 | 1,963 | -276 | 1,109 | 0 |
| 30 Sep 16 | 2,125 | -206 | 1,180 | 0 |
| 30 Jun 16 | 2,171 | -8 | 1,050 | 0 |
| 31 Mar 16 | 2,166 | 225 | 785 | 0 |
| 31 Dec 15 | 2,210 | 231 | 753 | 0 |
| 30 Sep 15 | 2,028 | 213 | 634 | 0 |
| 30 Jun 15 | 2,123 | 215 | 588 | 0 |
| 31 Mar 15 | 2,258 | 210 | 606 | 0 |
| 31 Dec 14 | 2,203 | 194 | 590 | 0 |
| 30 Sep 14 | 2,124 | 188 | 561 | 0 |
| 30 Jun 14 | 2,045 | 240 | 543 | 0 |
| 31 Mar 14 | 1,876 | 200 | 560 | 0 |
| 31 Dec 13 | 1,736 | 180 | 539 | 0 |
Quality Earnings: 002215 has high quality earnings.
Growing Profit Margin: 002215's current net profit margins (8.9%) are higher than last year (7.5%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 002215's earnings have grown by 13.7% per year over the past 5 years.
Accelerating Growth: 002215's earnings growth over the past year (44.3%) exceeds its 5-year average (13.7% per year).
Earnings vs Industry: 002215 earnings growth over the past year (44.3%) exceeded the Chemicals industry -5.3%.
Return on Equity
High ROE: 002215's Return on Equity (9.8%) is considered low.